Skip to main content

Year: 2023

Bunker Hill Provides October 2023 Restart Project Update

Photo 1Initial earthwork in support of portalPhoto 2First set of steel sets being positionedPhoto 3Spreaders inserted prior to burying steel setsFigure 1Avista Utilities working to install upgraded power from the nearby substation up Division Street in Wardner and to siteFigure 2Wilson Construction Co. installing overhead powerlines on Bunker Hill propertyFigure 3Overhead power installation complete at WardnerInfographicPreliminary Dry Stack Tailings Storge Facility designs for Bunker HillPhoto 414 Oct – Newly completed and enlarged Russell PortalJoin Richard Williams, Sam Ash, and Tom Francis for a live virtual event from Bunker Hill Site as they unveil the monumental upgrade to the Russell Portal, along with providing a general update from the field on October...

Continue reading

Casa Systems’ Axyom® Virtual Converged Cable Access Platform (vCCAP) Achieves Unprecedented Combination of Speed, Capacity, and Power Savings with Intel’s 4th Generation Xeon® Scalable Processors

Revolutionary Axyom® vCCAP with Intel processors paves the way for enhanced cable provider scalability, savings, and flexibility Axyom vCCAP solution improves throughput per vCPU compared to leading competitors’ stated throughput Dramatic Axyom vCCAP performance provides advantages to cable operators embracing network functions virtualizationANDOVER, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) — Casa Systems (Nasdaq: CASA), provider of cloud-native network solutions serving Tier 1 and regional service providers worldwide, today announced its Axyom® virtual Converged Cable Access Platform (vCCAP) with Intel’s 4th Generation Xeon Scalable Processors achieved a 65% increase in capacity and 7x increase in density while simultaneously demonstrating significant power savings over previous generation vCCAP solutions. This unprecedented combination...

Continue reading

RAPT Therapeutics Announces Two FLX475 Presentations at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

SOUTH SAN FRANCISCO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced it will present two posters on FLX475, its oncology drug candidate, at the Society for Immunotherapy of Cancer 2023 Annual Meeting taking place November 3-5, 2023 in San Diego, CA. Poster presentation details:Title: Phase 2 safety and efficacy of oral CCR4 antagonist FLX475 (tivumecirnon)plus pembrolizumab in subjects with non-small cell lung cancer not previouslytreated with checkpoint inhibitorAbstract Number: 629-CDate & Time: Friday, November 3, 2023; 9:00 a.m. – 7:00 p.m. PTLocation: Exhibit...

Continue reading

Aware Sets Third Quarter 2023 Webcast for Wednesday, November 1, 2023 at 5:00 p.m. Eastern Time

BURLINGTON, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a leading authentication company applying proven and trusted adapted authentication to solve everyday business challenges with biometrics, will hold a webcast on Wednesday, November 1, 2023 at 5:00 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2023. Financial results will be issued in a press release prior to the call. Aware management will host the webcast presentation, followed by a question-and-answer session. Date: Wednesday, November 1, 2023Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)Webcast: Register Here Interested parties may submit questions in advance of the webcast by emailing AWRE@gateway-grp.com. The presentation will be made available for replay in the investor relations section of...

Continue reading

Sage launches Sage HR integration for Sage 50 to simplify SMBs’ business processes  

New integration streamlines accounting, HR and Payroll processes to make work and data flow for customers ATLANTA, Oct. 18, 2023 (GLOBE NEWSWIRE) — Sage, the leader in accounting, financial, HR and payroll technology for small and mid-sized businesses (SMBs), today announce the launch of Sage HR for Sage 50 in the U.S. and Canada. The industry-first solution delivers powerful integration between accounting, HR and payroll processes, allowing teams to be more agile and keep up with the demands of a modern workforce. The Sage HR integration is available exclusively to Sage 50 customers with a Payroll service plan.  Sage 50 is easily integrated with Sage HR and delivers helpful tools for employees to self-serve whenever and wherever they are through a mobile app. Businesses will be able to effortlessly connect data from various parts...

Continue reading

CareCloud Unveils CirrusAI: An Innovative Generative AI Solution for Healthcare

SOMERSET, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for outpatient practices nationwide, today announced the launch of the first three features of CirrusAI, its innovative generative AI platform. CirrusAI is designed to serve as a digital healthcare assistant, helping to enhance clinical decision-making, streamline workflows, reduce administrative burdens, optimize revenue management, and promote patient-centered care. CirrusAI is a state-of-the-art healthcare AI platform that was first introduced in July 2023. It is powered by Google Cloud’s Vertex AI and is poised to help reshape how healthcare professionals deliver patient care and manage their office workflows. CirrusAI will offer a comprehensive suite of features in the future. The initial...

Continue reading

BullFrog AI to Present at Benzinga All Access Event on October 20

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that Vin Singh, Founder and CEO of BullFrog AI, will present during Benzinga’s All Access investor event on Friday, October 20, 2023, at 11:00 a.m. ET. Webcast: https://www.youtube.com/watch?v=UyGTBVOidb8 A live video webcast will be available using the link above – an archived replay will be made available after the live event on the Benzinga YouTube Channel. For more information on Benzinga All Access, please contact your Benzinga representative. About BullFrog AIBullFrog...

Continue reading

VIVOPOWER SIGNS DEFINITIVE JOINT VENTURE AGREEMENT WITH DIGITAL TWIN TECHNOLOGY COMPANY, GEMINUM

VivoPower and Geminum team up to offer holistic end-to-end fleet electrification and decarbonisation solutions Geminum specialises in digital twin solutions for corporations seeking to implement decarbonisation solutions in a safe, cost-effective and integrated manner Geminum leadership team have 20 years of combined digital twin and change management experience, particularly in the mining industry LONDON, Oct. 18, 2023 (GLOBE NEWSWIRE) — NASDAQ listed B Corp, VivoPower International PLC (“VivoPower”), is pleased to announce that it has signed a Joint Venture (“JV Agreement”) with Geminum Pty Ltd (“Geminum”), a specialist digital twin technology company founded in Australia, to design, test and implement digital twins of Tembo electric utility vehicles and ancillary VivoPower sustainable energy solutions (VivoSES). These digital...

Continue reading

Global CRISPR/CAS 9 Technology Market Size to Reach USD 13,072.73 Million in 2032 |Emergen Research

CRISPR/CAS 9 technology market revenue growth is due to increasing support from governments and rising private funding Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) — The global CRISPR/CAS 9 technology market size is expected to reach USD 13,072.73 Million at a steady revenue CAGR of 20.4% in 2032, according to latest analysis by Emergen Research. Steady CRISPR/CAS 9 market revenue growth is due to ability for researchers and experts to use the technology to correct genetic defects, yield better crop varieties, and treat human diseases. CAS 9 is an enzyme that acts as a pair of molecular scissors and can cut two strands of DNA at a specific location in the genome so that bits of DNA can be added or removed. Technological advancements in CRISPR/CAS 9 has revolutionized areas of cancer research and treatment. Currently, it has become...

Continue reading

Polyurethane Catalysts Market to Surpass 105.29 Billion by 2030 Drives Due to Industrial Growth

SkyQuest projects that the polyurethane catalysts market will attain a USD 105.29 billion value by 2030, with a CAGR of 4.4% over the forecast period (2023-2030). The polyurethane catalysts market is driven by continuous innovation in catalyst technologies, leading to improved performance and process efficiency in polyurethane production. Manufacturers are investing in research to develop catalysts that enable customized material properties and enhanced sustainability, catering to diverse industrial applications. Westford USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, demand for polyurethane catalysts is surging due to the expansion of end-use sectors such as construction, automotive, and furniture. The need for high-performance polyurethane materials rises, driving the polyurethane catalysts market as these industries...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.